Abstract
2,3-Dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine and a few of its 12-substituted analogs are active as TOP1-targeting agents. Studies were performed to further evaluate the potential of this series of non-camptothecin TOP1-targeting agents. The influence of a hydroxymethyl, formyl, N,N-dimethylaminomethyl, 2-(N,N-dimethylamino)ethyl, 3-(N,N-dimethylamino)propyl), and 4-(N,N-dimethylamino)butyl substituent at the 12-position on TOP1-targeting activity and tumor cell growth was evaluated. In addition, the relative pharmacologic activities of the 12-carboxamide analog, as well as its N-methyl and N,N-dimethyl derivatives were assessed.
Original language | English |
---|---|
Pages (from-to) | 2877-2885 |
Number of pages | 9 |
Journal | Bioorganic and Medicinal Chemistry |
Volume | 17 |
Issue number | 7 |
DOIs | |
Publication status | Published - Apr 1 2009 |
Externally published | Yes |
Keywords
- Benzo[i]phenanthridines
- Cytotoxicity
- Structure-activity
- Topoisomerase I
ASJC Scopus subject areas
- Pharmaceutical Science
- Drug Discovery
- Organic Chemistry
- Molecular Medicine
- Molecular Biology
- Clinical Biochemistry
- Biochemistry